Patents by Inventor Robert Cafferkey

Robert Cafferkey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120014872
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Application
    Filed: August 17, 2011
    Publication date: January 19, 2012
    Applicant: diaDexus, Inc.
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey
  • Patent number: 8029787
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: October 4, 2011
    Assignee: diaDexus, Inc.
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey
  • Patent number: 7858325
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: December 28, 2010
    Assignee: Diadexus, Inc.
    Inventors: Shujath Ali, Yongming Sun, Susana Salceda, Herve Recipon, Robert Cafferkey
  • Publication number: 20100284910
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Application
    Filed: May 26, 2010
    Publication date: November 11, 2010
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey
  • Publication number: 20100167278
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging and prognosticating prostate cancer.
    Type: Application
    Filed: December 22, 2008
    Publication date: July 1, 2010
    Inventors: Shujath Ali, Susana Salceda, Yongming Sun, Robert Cafferkey
  • Patent number: 7737255
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: June 15, 2010
    Assignee: Diadexus, Inc.
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey
  • Publication number: 20090142262
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Application
    Filed: August 27, 2008
    Publication date: June 4, 2009
    Inventors: Susan Salceda, Herve Recipon, Robert Cafferkey
  • Patent number: 7470514
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging and prognosticating prostate cancer.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: December 30, 2008
    Assignee: diaDexus, Inc.
    Inventors: Shujath Ali, Susana Salceda, Yongming Sun, Robert Cafferkey
  • Patent number: 7432064
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: October 7, 2008
    Assignee: diaDexus, Inc.
    Inventors: Susana Salceda, Herve Recipon, Robert Cafferkey
  • Publication number: 20080175788
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Application
    Filed: March 6, 2008
    Publication date: July 24, 2008
    Inventors: Shujath M. Ali, Yongming Sun, Susana Salceda, Herve Recipon, Robert Cafferkey
  • Publication number: 20080107596
    Abstract: The present invention provides new markers and methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating breast cancer.
    Type: Application
    Filed: May 23, 2007
    Publication date: May 8, 2008
    Inventors: Susana Salceda, Robert Cafferkey, Herve Recipon, Yongming Sun
  • Patent number: 7364862
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: August 30, 2004
    Date of Patent: April 29, 2008
    Assignee: diaDexus, Inc.
    Inventors: Shujath M. Ali, Yongming Sun, Susana Salceda, Herve Recipon, Robert Cafferkey
  • Patent number: 7326529
    Abstract: The present invention provides new markers and methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: February 5, 2008
    Assignee: diaDexus, Inc.
    Inventors: Shujath Ali, Robert Cafferkey, Herve Recipon, Yongming Sun
  • Patent number: 7238471
    Abstract: Diagnostic markers for breast cancer referred to herein breast cancer specific genes or BCSGs are provided. Also provided are methods for using BCSGs to detect, diagnose, monitor, stage, prognosticate, image and treat breast cancer. Antibodies which specifically bind BCSGs and methods of using these antibodies to image and treat breast cancer are also provided.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: July 3, 2007
    Assignee: DiaDexus, Inc.
    Inventors: Susana Salceda, Robert Cafferkey, Herve Recipon, Yongming Sun
  • Publication number: 20060019322
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research.
    Type: Application
    Filed: September 19, 2005
    Publication date: January 26, 2006
    Inventors: Shujath Ali, Herve Recipon, Robert Cafferkey, Yongming Sun
  • Patent number: 6960433
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: November 1, 2005
    Assignee: diaDexus, Inc.
    Inventors: Shujath M. Ali, Yongming Sun, Susana Salceda, Herve Recipon, Robert Cafferkey
  • Publication number: 20050181413
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic ovary cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovary tissue, identifying ovary tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovary tissue for treatment and research.
    Type: Application
    Filed: February 14, 2005
    Publication date: August 18, 2005
    Inventors: Susana Salceda, Roberto Macina, Herve Recipon, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20050164278
    Abstract: The invention relates to BSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: February 7, 2005
    Publication date: July 28, 2005
    Inventors: Susana Salceda, Robert Cafferkey
  • Publication number: 20050158242
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: July 21, 2005
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey
  • Publication number: 20050158241
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: July 21, 2005
    Inventors: Susana Salceda, Yongming Sun, Herve Recipon, Robert Cafferkey